Literature DB >> 21952835

Mucormycosis in Mato Grosso, Brazil: a case reports, caused by Rhizopus microsporus var. oligosporus and Rhizopus microsporus var. rhizopodiformis.

Luciano Corrêa Ribeiro1, Bodo Wanke, Manuela da Silva, Luciana Basili Dias, Renato Mello, Fernando Artur Pena Borges Canavarros, Diniz Pereira Leite, Rosane Christine Hahn.   

Abstract

We identified the etiological agents responsible for two fatal cases of rhinocerebral mucormycosis with the classical risk factor for uncontrolled type II diabetes mellitus. Their initial symptoms did not point immediately to the suspicion of mucormycosis. Case 1, caused by Rhizopus microsporus var. oligosporus, was a 52-year-old man who presented with a painful pimple on his nose, which evolved with swelling, erythema, and a central pustule on his right hemiface suspected to be cellulitis. After 7 days of antibiotic treatment, the patient worsened with signs of sepsis and the lesion evolved to necrosis involving all his right face. Case 2, caused by Rhizopus microsporus var. rhizopodiformis, was a 57-year-old woman placed on continuous therapy with azathioprine and corticoids after a renal transplant due to chronic arterial hypertension and uncontrolled type II diabetes mellitus. Because she was suspected to have sepsis, the patient was treated with broad-spectrum antibiotics and mechanical ventilation, yet she deteriorated. Because Candida spp. were isolated from urine and a BAL, she was treated with fluconazole for 10 days, then substituted by caspofungin. Two weeks later, she presented with exophthalmus of the left eye that was surrounded by a large inflammatory and necrotic area. Both patients were the diagnosed with mucormycosis via direct microscopy of necrotic material prior to their death.

Entities:  

Mesh:

Year:  2011        PMID: 21952835     DOI: 10.1007/s11046-011-9472-0

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  29 in total

Review 1.  Mucormycoses.

Authors:  J Eucker; O Sezer; B Graf; K Possinger
Journal:  Mycoses       Date:  2001       Impact factor: 4.377

2.  Posaconazole as salvage therapy for zygomycosis.

Authors:  R N Greenberg; K Mullane; J-A H van Burik; I Raad; M J Abzug; G Anstead; R Herbrecht; A Langston; K A Marr; G Schiller; M Schuster; J R Wingard; C E Gonzalez; S G Revankar; G Corcoran; R J Kryscio; R Hare
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

3.  Zygomycosis after prolonged use of voriconazole in immunocompromised patients with hematologic disease: attention required.

Authors:  Stéphane Vigouroux; Odile Morin; Philippe Moreau; Françoise Méchinaud; Nadine Morineau; Béatrice Mahé; Patrice Chevallier; Thierry Guillaume; Viviane Dubruille; Jean-Luc Harousseau; Noël Milpied
Journal:  Clin Infect Dis       Date:  2005-01-25       Impact factor: 9.079

4.  Breakthrough Candida krusei fungemia during fluconazole prophylaxis followed by breakthrough zygomycosis during caspofungin therapy in a patient with severe aplastic anemia who underwent stem cell transplantation.

Authors:  Corrado Girmenia; Maria Luisa Moleti; Alessandra Micozzi; Anna Paola Iori; Walter Barberi; Robin Foà; Pietro Martino
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

Review 5.  Fungal sinusitis.

Authors:  R D deShazo; K Chapin; R E Swain
Journal:  N Engl J Med       Date:  1997-07-24       Impact factor: 91.245

Review 6.  Zygomycosis: the re-emerging fungal infection.

Authors:  M Chayakulkeeree; M A Ghannoum; J R Perfect
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-04       Impact factor: 3.267

Review 7.  Zygomycosis: an emerging fungal infection.

Authors:  Jack Brown
Journal:  Am J Health Syst Pharm       Date:  2005-12-15       Impact factor: 2.637

Review 8.  Treatment of zygomycosis: current and new options.

Authors:  Thomas R Rogers
Journal:  J Antimicrob Chemother       Date:  2008-01       Impact factor: 5.790

Review 9.  Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment.

Authors:  R M Prabhu; R Patel
Journal:  Clin Microbiol Infect       Date:  2004-03       Impact factor: 8.067

10.  Breakthrough Scedosporium prolificans infection while receiving voriconazole prophylaxis in an allogeneic stem cell transplant recipient.

Authors:  S Y C Tong; A Y Peleg; J Yoong; R Handke; J Szer; M Slavin
Journal:  Transpl Infect Dis       Date:  2007-07-01       Impact factor: 2.228

View more
  4 in total

Review 1.  Chlamydospores of Rhizopus microsporus var. rhizopodiformis in tissue of pulmonary mucormycosis.

Authors:  Masatomo Kimura; Kazuko Nishimura; Eisuke Enoki; Takaaki Chikugo; Osamu Maenishi
Journal:  Mycopathologia       Date:  2012-06-26       Impact factor: 2.574

2.  Rhino-Orbital-Cerebral Mycosis and Extranodal Natural Killer or/and T-Cell Lymphoma, Nasal Type.

Authors:  Dong Ming Li; Li De Lun
Journal:  Front Med (Lausanne)       Date:  2022-06-17

3.  Fatal rhinocerebral mucormycosis in a patient with ulcerative colitis receiving azathioprine and corticosteroid.

Authors:  Narges Najafi; Firoozeh Kermani; Nahid Gholinejad Ghadi; Seyed Reza Aghili; Zahra Seifi; Emmanuel Roilides; Tahereh Shokohi
Journal:  Curr Med Mycol       Date:  2019-03

4.  Mucormycosis in a patient with acute myeloid leukemia successfully treated with liposomal amphotericin B associated with deferasirox and hyperbaric oxygen.

Authors:  Eduardo Flavio Oliveira Ribeiro; Vitorino Modesto dos Santos; Guilherme Teixeira Guimarães Paixão; Leonardo Rodrigues Cruz; Milena Zamian Danilow; Vinicius Ferreira Campos
Journal:  Mycopathologia       Date:  2013-02-27       Impact factor: 2.574

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.